Federal Panel Allows Diabetes Drug Avandia To Stay On Market

MIAMI – JULY 14: A bottle and pills of the diabetes drug, Avandia are seen on July 14, 2010 in Miami, Florida. Today, the U.S. Food and Drug Administration panel voted to recommend that GlaxoSmithKline PLC’s (GSK) diabetes drug, Avandia, remain on the market despite concerns that the product could raise the risk of heart attacks. (Photo by illustration Joe Raedle/Getty Images)

Leave a Comment